Multicenter, Randomized, Double-Blind, Placebo - Controlled, Parallel Group, Efficacy and Safety Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure.

Trial Profile

Multicenter, Randomized, Double-Blind, Placebo - Controlled, Parallel Group, Efficacy and Safety Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Apr 2012

At a glance

  • Drugs Lixivaptan (Primary)
  • Indications Heart failure
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Cardiokine
  • Most Recent Events

    • 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.
    • 24 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top